Kshirsagar T A, Fang X, Portoghese P S
Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA.
J Med Chem. 1998 Jul 2;41(14):2657-60. doi: 10.1021/jm980209b.
The 14-hydroxy group is known to increase the antagonist potency of mu-selective opioid ligands. To investigate the role of this group at the delta opioid receptor, the 14-desoxy analogues (7 and 9) of the delta-selective ligands, naltrindole (1, NTI) and spiroindanyloxymorphone (2, SIOM), have been synthesized and tested. The in vitro pharmacologic activities of 7 and 9 suggest that the 14-hydroxy group plays an important role in determining the delta selectivity and potency of NTI and SIOM.
已知14-羟基可增强μ-选择性阿片样物质配体的拮抗效力。为研究该基团在δ阿片受体上的作用,已合成并测试了δ-选择性配体纳曲吲哚(1,NTI)和螺环茚满氧基吗啡(2,SIOM)的14-脱氧类似物(7和9)。7和9的体外药理活性表明,14-羟基在决定NTI和SIOM的δ选择性和效力方面起着重要作用。